MacroChem completes patient enrollment for Phase II trial of EcoNail for treatment of onychomycosis
MacroChem Corporation has completed patient enrollment in a Phase II efficacy study for EcoNail, a topical antifungal treatment for onychomycosis. The company aims to assess early signs of efficacy and collect 24-week interim data later this year.